Oxford BioTherapeutics Alternatives & Competitors
12 companies similar to Oxford BioTherapeutics — Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Context Therapeutics
Advancing T Cell Engagers for Solid Tumors
Philadelphia, United Stat...
Synaffix
A Lonza Company
Oss, The Netherlands
OncoResponse
Interrogating for Cures
Houston, United States
Basecamp Research
Beyond Known Biology: AI company dedicated to using nature to solve the life sciences' mos...
London, United Kingdom
Track all Oxford BioTherapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
T-knife Therapeutics
T-knife uses a mouse platform to create human TCRs for cancer treatment without modificati...
San Francisco, United Sta...
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
BioArdis
Motivated By Science
San Diego, United States
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
Septerna
Bringing a new era of GPCR medicines to patients with its Native Complex Platform™.
South San Francisco, Unit...
Oncoheroes Biosciences
Biotech Company 100% Focused on Pediatric Cancer Drug Development
Boston, United States
Promatix Biosciences Ltd
Using multi-omics to develop the next generation of cancer therapeutics
London, United Kingdom
Mabqi
Your key partner for breakthrough antibody discovery
Grabels, France
About Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Development of targeted cancer therapies, Integration of OGAP-Verify proteomic platform, Clinical-stage asset management, Therapeutic antibody generation
Oncology patients, Pharmaceutical partners, Biotechnology collaborators
Clinical Stage Oncology, Immuno-Oncology, Antibody-Drug Conjugates, Cancer Therapeutics, Immune Checkpoint Mechanisms, Targeted Medicines, OGAP Platform, Cancer Membrane Proteomics, Human Protein Databases, Companion Diagnostics, Discovery Partnerships, Novel Antibody Therapeutics, Pipeline Development, Disease Management, Antibody Development Partnerships
B2B, Platform, API
Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Oxford BioTherapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Oxford BioTherapeutics on 22 Mar 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
